{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-21-216533","form_type":"8-K","ticker":"EW","cik":"0001099800","company_name":"Edwards Lifesciences Corp","filed_at":"2021-07-15T23:59:59+00:00","discovered_at":"2026-05-14T18:04:17.149584+00:00","generated_at":"2026-06-30T04:59:34.030063+00:00","sec_items":["5.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Edwards Lifesciences amends bylaws to allow virtual meetings and exclusive federal forum","bullets":["Board adopted amended bylaws on July 15, 2021, authorizing virtual-only stockholder meetings and electronic delivery of notices.","Advance notice provisions now limit director nominees to the number of seats up for election and require nominator to be a stockholder of record.","Exclusive forum clause designates federal district courts for claims arising under the Securities Act of 1933.","Electronic proxies, written consents, and electronic signatures are explicitly permitted in accordance with Delaware law updates.","Stock certificates may now be signed by any two authorized officers, removing prior specified officer combinations."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-21-216533","json":"https://secwatch.observer/filing/0001193125-21-216533.json","markdown":"https://secwatch.observer/filing/0001193125-21-216533.md","text":"https://secwatch.observer/filing/0001193125-21-216533.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1099800/000119312521216533/0001193125-21-216533-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1099800/000119312521216533/d111792d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-30T04:59:34.030063+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}